261 related articles for article (PubMed ID: 28676438)
1. Parathyroid hormone inhibits Notch signaling in osteoblasts and osteocytes.
Zanotti S; Canalis E
Bone; 2017 Oct; 103():159-167. PubMed ID: 28676438
[TBL] [Abstract][Full Text] [Related]
2. Glucocorticoids inhibit notch target gene expression in osteoblasts.
Zanotti S; Yu J; Adhikari S; Canalis E
J Cell Biochem; 2018 Jul; 119(7):6016-6023. PubMed ID: 29575203
[TBL] [Abstract][Full Text] [Related]
3. Parathyroid Hormone Induces Bone Cell Motility and Loss of Mature Osteocyte Phenotype through L-Calcium Channel Dependent and Independent Mechanisms.
Prideaux M; Dallas SL; Zhao N; Johnsrud ED; Veno PA; Guo D; Mishina Y; Harris SE; Bonewald LF
PLoS One; 2015; 10(5):e0125731. PubMed ID: 25942444
[TBL] [Abstract][Full Text] [Related]
4. Canonical Notch activation in osteocytes causes osteopetrosis.
Canalis E; Bridgewater D; Schilling L; Zanotti S
Am J Physiol Endocrinol Metab; 2016 Jan; 310(2):E171-82. PubMed ID: 26578715
[TBL] [Abstract][Full Text] [Related]
5. gp130 in late osteoblasts and osteocytes is required for PTH-induced osteoblast differentiation.
Standal T; Johnson RW; McGregor NE; Poulton IJ; Ho PW; Martin TJ; Sims NA
J Endocrinol; 2014 Nov; 223(2):181-90. PubMed ID: 25228504
[TBL] [Abstract][Full Text] [Related]
6. Parathyroid hormone signaling in mature osteoblasts/osteocytes protects mice from age-related bone loss.
Uda Y; Saini V; Petty CA; Alshehri M; Shi C; Spatz JM; Santos R; Newell CM; Huang TY; Kochen A; Kim JW; Constantinou CK; Saito H; Held KD; Hesse E; Pajevic PD
Aging (Albany NY); 2021 Dec; 13(24):25607-25642. PubMed ID: 34968192
[TBL] [Abstract][Full Text] [Related]
7. EphrinB2/EphB4 inhibition in the osteoblast lineage modifies the anabolic response to parathyroid hormone.
Takyar FM; Tonna S; Ho PW; Crimeen-Irwin B; Baker EK; Martin TJ; Sims NA
J Bone Miner Res; 2013 Apr; 28(4):912-25. PubMed ID: 23165727
[TBL] [Abstract][Full Text] [Related]
8. Low-dose PTH increases osteoblast activity via decreased Mef2c/Sost in senescent osteopenic mice.
Saidak Z; Le Henaff C; Azzi S; Marty C; Marie PJ
J Endocrinol; 2014 Oct; 223(1):25-33. PubMed ID: 25056116
[TBL] [Abstract][Full Text] [Related]
9. The Notch pathway regulates the bone gain induced by PTH anabolic signaling.
Delgado-Calle J; McAndrews K; Wu G; Orr AL; Ferrari A; Tu X; Srinivasan V; Roodman GD; Ebetino FH; Boeckman RK; Bellido T
FASEB J; 2022 Mar; 36(3):e22196. PubMed ID: 35137455
[TBL] [Abstract][Full Text] [Related]
10. Parathyroid hormone (PTH)/PTH-related peptide type 1 receptor (PPR) signaling in osteocytes regulates anabolic and catabolic skeletal responses to PTH.
Saini V; Marengi DA; Barry KJ; Fulzele KS; Heiden E; Liu X; Dedic C; Maeda A; Lotinun S; Baron R; Pajevic PD
J Biol Chem; 2013 Jul; 288(28):20122-34. PubMed ID: 23729679
[TBL] [Abstract][Full Text] [Related]
11. Nuclear factor of activated T-cells (NFAT)C2 inhibits Notch receptor signaling in osteoblasts.
Zanotti S; Smerdel-Ramoya A; Canalis E
J Biol Chem; 2013 Jan; 288(1):624-32. PubMed ID: 23166323
[TBL] [Abstract][Full Text] [Related]
12. Amphiregulin-EGFR signaling mediates the migration of bone marrow mesenchymal progenitors toward PTH-stimulated osteoblasts and osteocytes.
Zhu J; Siclari VA; Liu F; Spatz JM; Chandra A; Divieti Pajevic P; Qin L
PLoS One; 2012; 7(12):e50099. PubMed ID: 23300521
[TBL] [Abstract][Full Text] [Related]
13. Chronic elevation of parathyroid hormone in mice reduces expression of sclerostin by osteocytes: a novel mechanism for hormonal control of osteoblastogenesis.
Bellido T; Ali AA; Gubrij I; Plotkin LI; Fu Q; O'Brien CA; Manolagas SC; Jilka RL
Endocrinology; 2005 Nov; 146(11):4577-83. PubMed ID: 16081646
[TBL] [Abstract][Full Text] [Related]
14. Effects of histone deacetylase inhibitor Scriptaid and parathyroid hormone on osteocyte functions and metabolism.
Sun N; Uda Y; Azab E; Kochen A; Santos RNCE; Shi C; Kobayashi T; Wein MN; Divieti Pajevic P
J Biol Chem; 2019 Jun; 294(25):9722-9733. PubMed ID: 31068415
[TBL] [Abstract][Full Text] [Related]
15. Does osteocytic SOST suppression mediate PTH bone anabolism?
Kramer I; Keller H; Leupin O; Kneissel M
Trends Endocrinol Metab; 2010 Apr; 21(4):237-44. PubMed ID: 20074973
[TBL] [Abstract][Full Text] [Related]
16. The regulatory roles of Notch in osteocyte differentiation via the crosstalk with canonical Wnt pathways during the transition of osteoblasts to osteocytes.
Shao J; Zhou Y; Xiao Y
Bone; 2018 Mar; 108():165-178. PubMed ID: 29331299
[TBL] [Abstract][Full Text] [Related]
17. Intermittent parathyroid hormone administration counteracts the adverse effects of glucocorticoids on osteoblast and osteocyte viability, bone formation, and strength in mice.
Weinstein RS; Jilka RL; Almeida M; Roberson PK; Manolagas SC
Endocrinology; 2010 Jun; 151(6):2641-9. PubMed ID: 20410195
[TBL] [Abstract][Full Text] [Related]
18. Effects of Sex and Notch Signaling on the Osteocyte Cell Pool.
Canalis E; Schilling L; Zanotti S
J Cell Physiol; 2017 Feb; 232(2):363-370. PubMed ID: 27192486
[TBL] [Abstract][Full Text] [Related]
19. Notch signaling is involved in Fgf23 upregulation in osteocytes.
Tamamura Y; Sakamoto K; Katsube KI; Yamaguchi A
Biochem Biophys Res Commun; 2019 Oct; 518(2):233-238. PubMed ID: 31420162
[TBL] [Abstract][Full Text] [Related]
20. Parathyroid hormone stimulates expression of the Notch ligand Jagged1 in osteoblastic cells.
Weber JM; Forsythe SR; Christianson CA; Frisch BJ; Gigliotti BJ; Jordan CT; Milner LA; Guzman ML; Calvi LM
Bone; 2006 Sep; 39(3):485-93. PubMed ID: 16647886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
